Correlation Between Serina Therapeutics and NetEase

Can any of the company-specific risk be diversified away by investing in both Serina Therapeutics and NetEase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Serina Therapeutics and NetEase into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Serina Therapeutics and NetEase, you can compare the effects of market volatilities on Serina Therapeutics and NetEase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Serina Therapeutics with a short position of NetEase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Serina Therapeutics and NetEase.

Diversification Opportunities for Serina Therapeutics and NetEase

-0.15

Correlation Coefficient

Serina Therapeutics  NetEase

Good diversification

The 3 months correlation between Serina and NetEase is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Serina Therapeutics and NetEase in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetEase and Serina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Serina Therapeutics are associated (or correlated) with NetEase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetEase has no effect on the direction of Serina Therapeutics i.e., Serina Therapeutics and NetEase go up and down completely randomly.

Pair Corralation between Serina Therapeutics and NetEase

Considering the 90-day investment horizon Serina Therapeutics is expected to generate 3.63 times more return on investment than NetEase. However, Serina Therapeutics is 3.63 times more volatile than NetEase. It trades about 0.07 of its potential returns per unit of risk. NetEase is currently generating about 0.1 per unit of risk. If you would invest  526.00  in Serina Therapeutics on September 21, 2024 and sell it today you would earn a total of  27.00  from holding Serina Therapeutics or generate 5.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Serina Therapeutics  vs.  NetEase

Serina Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

NetEase

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NetEase are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, NetEase unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Serina Therapeutics and NetEase

The main advantage of trading using opposite Serina Therapeutics and NetEase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Serina Therapeutics position performs unexpectedly, NetEase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetEase will offset losses from the drop in NetEase's long position.

The idea behind Serina Therapeutics and NetEase pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.